Print

Print


>BiDil is a combination of two generic drugs that are already
>available - hydralazine and isosorbide dinitrate. Because taking the
>combination would be convenient, the company does not expect its
>franchise to be undermined by the generic competition. NitroMed has
>not yet disclosed the price of the drug.

Presumably this should say "Because taking the combination would be
inconvenient..." In other words, NitroMed will charge African
Americans an exorbitant price for a drug that is simply a mixture of
two cheaply available generics. Clearly an irresistible combination
of racism and capitalism. --PG